Ho Robert Insider Trades

Insider Trading History

Track insider trading activity for Ho Robert. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Third Harmonic Bio
Third Harmonic Bio THRD
Chief Financial Officer
Holding Value $1.98M 367,955 shares
Last Trade
Mar 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.52M 598,955 shares
$4.20
$5.38
Third Harmonic Bio
Third Harmonic Bio THRD
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 06, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.94M 462,955 shares
$4.20
$5.38
Third Harmonic Bio
Third Harmonic Bio THRD
Chief Financial Officer
Holding Value $511k 95,000 shares
Last Trade
Oct 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.75M 95,000 shares
$18.40
$5.38
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Chief Financial Officer
Holding Value $244k 70,000 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Chief Financial Officer
Holding Value $663k 190,000 shares
Last Trade
Aug 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Chief Financial Officer
Holding Value $175k 50,000 shares
Last Trade
Mar 16, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Chief Financial Officer
Holding Value $314k 90,000 shares
Last Trade
Aug 10, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Chief Financial Officer
Holding Value $698k 200,000 shares
Last Trade
Mar 16, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up